In a recent decision, the Delhi High Court in Zeria Pharmaceutical Co. Ltd. v. Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) addressed the hurdles of patenting intermediate compounds in India. The court upheld the rejection of a divisional application for a new intermediate compound, reinforcing strict standards for pharmaceutical patents. What Are Intermediate Compounds? In pharma, intermediates...